✦ LIBER ✦

SUBDIVISION OF STAGE PT3 IN UROTHELIAL CARCINOMA OF THE RENAL PELVIS FACILITATES DETECTION OF PATIENTS AT HIGH RISK FOR FAILURE

✍ Scribed by C. Langner; G. Hutterer; T. Chromecki; P. Rehak; R. Zigeuner

Book ID: 119617049
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 50 KB
Volume: 5
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(06)60820-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UP-03.94: Subdivision of Stage pT3 in ur

UP-03.94: Subdivision of Stage pT3 in urothelial carcinoma of the renal pelvis facilitates detection of patients at high risk for failure

✍ R. Zigeuner; G. Hutterer; T. Chromecki; P. Rehak; C. Langner 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 83 KB

International validation of the prognost

International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis

✍ Marco Roscigno; Eugene K. Cha; Michael Rink; Christian Seitz; Giacomo Novara; Th 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB

638 INTERNATIONAL VALIDATION OF THE PROG

638 INTERNATIONAL VALIDATION OF THE PROGNOSTIC VALUE OF SUBCLASSIFICATION FOR AJCC STAGE PT3 UPPER TRACT UROTHELIAL CARCINOMA OF THE RENAL PELVIS

✍ Roscigno, Marco; Cha, Eugene; Seitz, Christian; Novara, Giacomo; Chromecki, Thom 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

Re: International Validation of the Prog

Re: International Validation of the Prognostic Value of Subclassification for AJCC Stage pT3 Upper Tract Urothelial Carcinoma of the Renal Pelvis

✍ Laguna, M. Pilar 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 111 KB

Proposal for Reclassification of the TNM

Proposal for Reclassification of the TNM Staging System in Patients with Locally Advanced (pT3–4) Renal Cell Carcinoma According to the Cancer-Related Outcome

✍ Vincenzo Ficarra; Giacomo Novara; Massimo Iafrate; Livio Cappellaro; Emiliano Br 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 529 KB

A MULTICENTRE, RANDOMISED, PHASE 3 TRIAL

A MULTICENTRE, RANDOMISED, PHASE 3 TRIAL OF A NOVEL, AUTOLOGOUS, THERAPEUTIC VACCINE (VITESPEN) VS. OBSERVATION AS ADJUVANT THERAPY IN PATIENTS AT HIGH RISK OF RECURRENCE AFTER NEPHRECTOMY FOR RENAL CELL CARCINOMA

✍ P. Mulders; C.G. Wood; S. Gorelov; K. Krajka; S. Mikhailov; A. Gorelov; S.D. Fos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB